Precision Biosciences (DTIL) EBITDA (2018 - 2026)
Precision Biosciences (DTIL) reported EBITDA of -$9.1 million for Q1 2026, up 58.96% year-over-year from -$5.7 million in Q1 2025, and down 172.55% quarter-over-quarter from $12.5 million in Q4 2025.
Precision Biosciences (DTIL) EBITDA (2018 - 2026) Analysis & Trends
Precision Biosciences (DTIL) has 9 years of EBITDA data on file, last reported at -$9.1 million in Q1 2026.
- EBITDA for Q1 2026 came in at -$9.1 million, up 58.96% year-over-year; the trailing twelve-month figure through Mar 2026 was -$39.1 million (up 11.29% YoY), and the FY2025 annual result was -$52.1 million, down 99.33% from the prior year.
- EBITDA fell to -$9.1 million in Q1 2026 per DTIL's latest filing, from $12.5 million in the prior quarter.
- Over five years, EBITDA peaked at $24.1 million in Q2 2024 and troughed at -$29.6 million in Q2 2022.
- A 5-year average of -$12.6 million and a median of -$14.7 million in 2022 frame the typical range for EBITDA.
- The sharpest annual moves came in 2024 and 2025: EBITDA surged 871.68% in 2024, then plunged 428.11% in 2025.
- A 5-year view of EBITDA shows it stood at -$12.1 million in 2022, then decreased by 22.97% to -$14.9 million in 2023, then sank by 66.86% to -$24.8 million in 2024, then soared by 150.34% to $12.5 million in 2025, then tumbled by 172.55% to -$9.1 million in 2026.
- Business Quant data shows DTIL's EBITDA at -$9.1 million in Q1 2026, $12.5 million in Q4 2025, and -$20.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.92 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -13.63 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -752,618.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Precision Biosciences | 168.99 Mn | 67.81 Mn | - | -9.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.08 Mn |
| Dec 31, 2025 | 12.51 Mn |
| Sep 30, 2025 | -20.67 Mn |
| Jun 30, 2025 | -21.88 Mn |
| Mar 31, 2025 | -22.11 Mn |
| Dec 31, 2024 | -24.85 Mn |
| Sep 30, 2024 | -21.28 Mn |
| Jun 30, 2024 | 24.15 Mn |
| Mar 31, 2024 | -4.19 Mn |
| Dec 31, 2023 | -14.89 Mn |
| Sep 30, 2023 | -12.36 Mn |
| Jun 30, 2023 | -3.13 Mn |
| Mar 31, 2023 | -13.35 Mn |
| Dec 31, 2022 | -12.11 Mn |
| Sep 30, 2022 | -14.68 Mn |
| Jun 30, 2022 | -29.55 Mn |
| Mar 31, 2022 | -27.34 Mn |
| Dec 31, 2021 | -30.72 Mn |
| Sep 30, 2021 | -11.54 Mn |
| Jun 30, 2021 | 21.63 Mn |